On the public citation graph

Hybrid mRNA Nano Vaccine Potentiates Antigenic Peptide Presentation and Dendritic Cell Maturation for Effective Cancer Vaccine Therapy and Enhances Response to Immune Checkpoint Blockade

https://doi.org/10.1002/adhm.202301261
0 signed · 81 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adhm.201900039openalex-snapshot
Simultaneous T Cell Activation and Macrophage Polarization to Promote Potent Tumor Suppression by Iron Oxide‐Embedded Large‐Pore Mesoporous Organosilica Core–Shell Nanospheres
inferredcites →https://doi.org/10.1002/adma.200901718openalex-snapshot
Small‐Molecule End‐Groups of Linear Polymer Determine Cell‐type Gene‐Delivery Efficacy
inferredcites →https://doi.org/10.1002/adma.201805116openalex-snapshot
Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium
inferredcites →https://doi.org/10.1002/adma.202109984openalex-snapshot
Rapid Surface Display of mRNA Antigens by Bacteria‐Derived Outer Membrane Vesicles for a Personalized Tumor Vaccine
inferredcites →https://doi.org/10.1007/s00262-022-03191-8openalex-snapshot
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studies
inferredcites →https://doi.org/10.1016/j.biomaterials.2021.121297openalex-snapshot
Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines
inferredcites →https://doi.org/10.1016/j.ccell.2014.09.007openalex-snapshot
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
inferredcites →https://doi.org/10.1016/j.ccell.2016.06.003openalex-snapshot
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
inferredcites →https://doi.org/10.1016/j.ccell.2020.07.004openalex-snapshot
Clinical Challenges of Immune Checkpoint Inhibitors
inferredcites →https://doi.org/10.1016/j.jconrel.2005.04.022openalex-snapshot
Formulation and characterization of poly (β amino ester) microparticles for genetic vaccine delivery
inferredcites →https://doi.org/10.1016/j.nano.2013.05.004openalex-snapshot
Polyethyleneimine and DNA nanoparticles-based gene therapy for acute lung injury
inferredcites →https://doi.org/10.1016/j.redox.2023.102795openalex-snapshot
Unlocking the power of NOX2: A comprehensive review on its role in immune regulation
inferredcites →https://doi.org/10.1016/j.trecan.2020.02.022openalex-snapshot
Turning Cold into Hot: Firing up the Tumor Microenvironment
inferredcites →https://doi.org/10.1021/acs.nanolett.9b04246openalex-snapshot
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
inferredcites →https://doi.org/10.1021/acsabm.2c00397openalex-snapshot
mRNA Delivery and Storage by Co-Assembling Nanostructures with Designer Oligopeptides
inferredcites →https://doi.org/10.1021/acsami.9b13135openalex-snapshot
Efficient and Robust Highly Branched Poly(β-amino ester)/Minicircle COL7A1 Polymeric Nanoparticles for Gene Delivery to Recessive Dystrophic Epidermolysis Bullosa Keratinocytes
inferredcites →https://doi.org/10.1021/acsbiomaterials.6b00503openalex-snapshot
Biodegradable Highly Branched Poly(β-Amino Ester)s for Targeted Cancer Cell Gene Transfection
inferredcites →https://doi.org/10.1021/acsnano.9b03334openalex-snapshot
Kinetic Control in Assembly of Plasmid DNA/Polycation Complex Nanoparticles
inferredcites →https://doi.org/10.1038/nature14426openalex-snapshot
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
inferredcites →https://doi.org/10.1038/nnano.2016.168openalex-snapshot
Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues
inferredcites →https://doi.org/10.1038/nrc3239openalex-snapshot
The blockade of immune checkpoints in cancer immunotherapy
inferredcites →https://doi.org/10.1038/nrd4278openalex-snapshot
mRNA-based therapeutics — developing a new class of drugs
inferredcites →https://doi.org/10.1038/nri.2017.131openalex-snapshot
Towards personalized, tumour-specific, therapeutic vaccines for cancer
inferredcites →https://doi.org/10.1038/s41467-018-04686-8openalex-snapshot
Mitochondrial reactive oxygen species regulate the induction of CD8+ T cells by plasmacytoid dendritic cells
inferredcites →https://doi.org/10.1038/s41467-019-11190-0openalex-snapshot
Highly branched poly(β-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells
inferredcites →https://doi.org/10.1038/s41467-022-32645-xopenalex-snapshot
Multifunctional nanoparticle potentiates the in situ vaccination effect of radiation therapy and enhances response to immune checkpoint blockade
inferredcites →https://doi.org/10.1038/s41551-018-0250-xopenalex-snapshot
Towards superior dendritic-cell vaccines for cancer therapy
inferredcites →https://doi.org/10.1038/s41568-021-00339-zopenalex-snapshot
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
inferredcites →https://doi.org/10.1038/s41571-020-00460-2openalex-snapshot
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
inferredcites →https://doi.org/10.1038/s41573-021-00163-yopenalex-snapshot
Emerging concepts in the science of vaccine adjuvants
inferredcites →https://doi.org/10.1038/s41573-021-00387-yopenalex-snapshot
Identification of neoantigens for individualized therapeutic cancer vaccines
inferredcites →https://doi.org/10.1038/s41577-019-0210-zopenalex-snapshot
Dendritic cells in cancer immunology and immunotherapy
inferredcites →https://doi.org/10.1038/s41586-018-0810-yopenalex-snapshot
Actively personalized vaccination trial for newly diagnosed glioblastoma
inferredcites →https://doi.org/10.1038/s41586-020-2537-9openalex-snapshot
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
inferredcites →https://doi.org/10.1038/s41587-019-0247-3openalex-snapshot
Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation
inferredcites →https://doi.org/10.1038/s41591-022-02061-1openalex-snapshot
The landscape of mRNA nanomedicine
inferredcites →https://doi.org/10.1038/s41598-020-60506-4openalex-snapshot
mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification
inferredcites →https://doi.org/10.1038/s43586-022-00104-yopenalex-snapshot
Nanodelivery of nucleic acids
inferredcites →https://doi.org/10.1039/c9tb02271fopenalex-snapshot
Recent advancements in polyethyleneimine-based materials and their biomedical, biotechnology, and biomaterial applications
inferredcites →https://doi.org/10.1039/d1cs00617gopenalex-snapshot
Emerging mRNA technologies: delivery strategies and biomedical applications
inferredcites →https://doi.org/10.1126/sciadv.1600102openalex-snapshot
The transition from linear to highly branched poly(β-amino ester)s: Branching matters for gene delivery
inferredcites →https://doi.org/10.1126/sciadv.abk2855openalex-snapshot
High-throughput and high-content bioassay enables tuning of polyester nanoparticles for cellular uptake, endosomal escape, and systemic in vivo delivery of mRNA
inferredcites →https://doi.org/10.1126/science.aay5967openalex-snapshot
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
inferredcites →https://doi.org/10.1126/scitranslmed.aav7431openalex-snapshot
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
inferredcites →https://doi.org/10.1146/annurev-bioeng-110220-031722openalex-snapshot
Current Developments and Challenges of mRNA Vaccines
inferredcites →https://doi.org/10.1146/annurev-immunol-100311-102839openalex-snapshot
Decisions About Dendritic Cells: Past, Present, and Future
inferredcites →https://doi.org/10.1186/s12929-017-0329-9openalex-snapshot
Cancer immunotherapies targeting the PD-1 signaling pathway
inferredcites →https://doi.org/10.2217/nnm-2021-0255openalex-snapshot
Immunotherapy for Cancer: Effects of Iron Oxide Nanoparticles on Polarization of Tumor-Associated Macrophages
inferredcites →https://doi.org/10.3389/fimmu.2017.01479openalex-snapshot
Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages
inferredcites →https://doi.org/10.3389/fimmu.2019.00168openalex-snapshot
Cold Tumors: A Therapeutic Challenge for Immunotherapy
inferredcites →https://doi.org/10.3389/fimmu.2021.693709openalex-snapshot
The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment
inferredcites →https://doi.org/10.3390/cancers14205107openalex-snapshot
Mannose and Hyaluronic Acid Dual-Modified Iron Oxide Enhances Neoantigen-Based Peptide Vaccine Therapy by Polarizing Tumor-Associated Macrophages
inferredcites →https://doi.org/10.3390/pharmaceutics12020102openalex-snapshot
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
inferredcites →https://doi.org/10.3390/vaccines7020037openalex-snapshot
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies
inferredcites →https://doi.org/10.7150/thno.71760openalex-snapshot
Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4766018openalex-extracted
inferred← citeshttps://doi.org/10.1002/adfm.202504465openalex-snapshot
Synthetic Strategy for mRNA Encapsulation and Gene Delivery with Nanoscale Metal‐Organic Frameworks
inferred← citeshttps://doi.org/10.1002/adtp.202400084openalex-snapshot
Fluorinated Chitosan‐Mediated Transepithelial Delivery of Intravesical Dual‐Drug Immunotherapeutic for Bladder Cancer Therapy
inferred← citeshttps://doi.org/10.1002/cac2.70002openalex-snapshot
Breaking barriers: Smart vaccine platforms for cancer immunomodulation
inferred← citeshttps://doi.org/10.1007/978-3-032-29006-9_11openalex-snapshot
Nanotechnology-Mediated Delivery of Vaccines in Cancer Management
inferred← citeshttps://doi.org/10.1007/978-981-95-3957-4_24openalex-snapshot
RNA-Based Therapeutics
inferred← citeshttps://doi.org/10.1007/s13402-026-01199-1openalex-snapshot
Next-generation neoantigen mRNA vaccines: Immuno-engineering strategies for precision cancer immunotherapy
inferred← citeshttps://doi.org/10.1007/s44368-025-00012-9openalex-snapshot
The RNA-based immunotherapy and future perspectives
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2025.123539openalex-snapshot
A leucine derivate-adjuvanted LNP vaccine enhances antitumor immunity through mTOR activation and metabolic reprograming in dendritic cells
inferred← citeshttps://doi.org/10.1016/j.carbpol.2026.125139openalex-snapshot
Hybridization of polysaccharide/lipid composite-based nanovesicles for precise delivery of drug/gene/protein in immunotherapy: A promising paradigm for precision cancer therapy
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2023.104198openalex-snapshot
Advances, opportunities and challenges in developing therapeutic cancer vaccines
inferred← citeshttps://doi.org/10.1016/j.ebiom.2024.105543openalex-snapshot
Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.04.039openalex-snapshot
Emerging advances in delivery systems for mRNA cancer vaccines
inferred← citeshttps://doi.org/10.1016/j.nano.2024.102776openalex-snapshot
Prophylactic and therapeutic cancer vaccine with continuous localized immunomodulation
inferred← citeshttps://doi.org/10.1021/acs.biomac.4c00442openalex-snapshot
Photothermal Particle-Loaded Panax Notoginseng Polysaccharide Cryogels As Personalized Tumor Vaccines
inferred← citeshttps://doi.org/10.1021/acsami.6c11314openalex-snapshot
Nanomedicine-Based Therapeutic Strategies for Next-Generation Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1039/d5nh00681copenalex-snapshot
Nanovaccines of polydopamine@tumor-associated antigens with robust prophylactic and therapeutic efficacy for cancer immunotherapy
inferred← citeshttps://doi.org/10.1039/d5sc05951hopenalex-snapshot
Poly(beta-amino esters): applications in immunology
inferred← citeshttps://doi.org/10.1039/d6pm00136jopenalex-snapshot
Co-formulation of IL-12 mRNA and doxorubicin in polymeric nanoparticles for simultaneous delivery in murine melanoma
inferred← citeshttps://doi.org/10.1039/d6tb00909copenalex-snapshot
Emerging biodegradable nanomaterials for innovative tumor immunotherapy
inferred← citeshttps://doi.org/10.1093/jleuko/qiae059openalex-snapshot
Optimization of a lipid nanoparticle–based protocol for RNA transfection into primary mononuclear phagocytes
inferred← citeshttps://doi.org/10.1097/cm9.0000000000003455openalex-snapshot
mRNA vaccines as cancer therapies
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000764openalex-snapshot
Improving the Efficacy of Cancer mRNA Vaccines
inferred← citeshttps://doi.org/10.1101/2024.07.24.604918openalex-snapshot
Second generation of LNP based mRNA vaccine leads to a T cell–inflamed tumor microenvironment favorable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumor model
inferred← citeshttps://doi.org/10.1186/s12943-025-02480-xopenalex-snapshot
Reversal of tumour immune evasion via enhanced MHC-Class-I antigen presentation by a dual-functional RNA regulated system
inferred← citeshttps://doi.org/10.3390/nano15020122openalex-snapshot
Nano-Oncologic Vaccine for Boosting Cancer Immunotherapy: The Horizons in Cancer Treatment
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.